Our clinical thesis
Metabolic health, designed for Indian bodies.
Built for the Indian phenotype. Safety first. Real science, and doctors who hold us to it.
Our clinical & scientific committee
They set our standards and sign off every protocol.
MBBS · MD (ABFM, USA) · MPH (USA) · PG Clinical Cardiology
PhD, Endocrinology (Rutgers) · Postdoc, Reproductive Endocrinology (UCSF)
Partner at Microsoft AI · Head, HLS Product Portfolio Strategy & Partnerships · Founder, Microsoft Clinical Apps Marketplace · Ex-Monitor Group
What we believe, and what we measure
Six numbers that shaped how we care.
Each one changed how we work. Tap a card to see the belief behind it, and what we test because of it.
See it for yourself
What the scale won’t tell you.
Same BMI, different risk.
Drag to set a BMI and compare how standard charts and Indian guidelines read it.
At 24.0, a standard chart says you’re "normal". Under Indian guidelines, this is already obesity, and the next question is how much of it sits around your belly. 1, 4
More interactive explainers are on the way: what a DEXA shows, stopping vs continuing, and your gut microbiome.
India deserves its own data.
Most GLP-1 evidence comes from trials run outside India. With consent, Steer’s anonymised, long-term data helps build a clearer picture of how Indian bodies respond, and feeds back into better care for every member.
We will never…
Lose well. Live well.
First consultation free →All clinical decisions, including whether GLP-1 medication is appropriate, are made independently by your doctor. Results vary by individual.